Catalyst Event
Merck and Co Inc (MRK) · Other
From Akros U.S. Tech 100 Protective Allocation Monthly Index (A100PAM)
6/8/2026, 12:00:00 AM
Merck and Gilead announced positive topline results from two Phase 3 studies for an oral HIV treatment on 2026-06-08; importance is estimated at Medium as it strengthens the long-term virology pipeline, expected.
Korean Translation
2026-06-08 HIV 치료제 3상 긍정적 결과 발표. 바이러스학 파이프라인 강화로 인한 약 5% 이상의 긍정적 영향이 예상되어 Medium으로 분류함, 예상됨.
Related Recent Events
Snowflake Inc (SNOW) · Earnings Release
Snowflake's next earnings release for Q2 fiscal year 2027 is scheduled for August 26, 2026, scheduled. This event is expected to have a medium impact as earnings reports typically drive price movements of at least 5%.
8/26/2026, 12:00:00 AM
Applied Materials Inc (AMAT) · Other
A quarterly dividend of $0.53 per share is expected, with an ex-dividend date of August 20, 2026. Low importance is assigned as standard dividend events typically result in a <5% price impact, expected.
8/20/2026, 12:00:00 AM
Keysight Technologies Inc (KEYS) · Earnings Release
Keysight's fiscal Q3 2026 earnings release is scheduled. Importance is estimated as Medium based on historical price volatility around earnings dates, scheduled.
8/18/2026, 12:00:00 AM
Applied Materials Inc (AMAT) · Earnings Release
The Q3 2026 earnings release is scheduled for August 13, 2026. Low importance is assigned as the announcement of a reporting date typically has a <5% price impact, scheduled.
8/13/2026, 12:00:00 AM
Cisco Systems Inc (CSCO) · Earnings Release
Cisco is scheduled to release its Q4 and full fiscal year 2026 earnings on August 12, 2026, scheduled. Market reaction estimated at ≥5% based on historical earnings volatility.
8/12/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Earnings Release
Q2 2026 earnings release scheduled. The company guided for revenue of approximately $11.2 billion, and analysts forecast EPS around $1.55-$1.60. High importance is estimated due to expected >10% volatility scheduled.
8/4/2026, 12:00:00 AM